Corbus Pharmaceuticals Holding Cash Flow Reinvestment Rate

Latest as of September 2021: 0.34x

Corbus Pharmaceuticals Holding cash flow reinvestment rate. Corbus Pharmaceuticals Holding (CRBP) has a Cash Flow Reinvestment Rate of 0.34x as of September 2021, reinvesting $290.50K (capex $7.70K plus investments $282.80K) from operating cash flow of $856.95K. Explore CRBP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.34x
(Capex + Investments) / Operating CF

Total Reinvested

$290.50K
Capex + Investments

Operating Cash Flow

$856.95K
USD

Capital Expenditures

$7.70K
USD

Corbus Pharmaceuticals Holding Cash Flow Reinvestment Rate by Year (None–None)

Corbus Pharmaceuticals Holding cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Corbus Pharmaceuticals Holding. For the full cash flow conversion analysis, see Corbus Pharmaceuticals Holding (CRBP) cash conversion ratio.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow